CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
Gabapentin +1 moredrug
Likely dose
Gabapentin 1200mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01265056
NCT01265056N/ACompleted
CompareCT.gov

The Effect of Neurontin on Pain Management in the Acutely Burned Patient

Lucy A Wibbenmeyer·interventional·Posted Dec 22, 2010·Updated Jan 23, 2018

In Brief

A clinical study evaluating Gabapentin and Placebo for Pain and Burn Injury. Completed, enrolled 53 participants across 1 site.

Detailed Summary

Burn patients have extreme pain. Opioids are the main agents used for analgesia. We therefore propose a single center study to fruther assess the efficacy of neuropathic agents in controlling the pain associated with acute thermal injury.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Burn Injury
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 22, 2010
Enrollment StartFeb 1, 2010
Primary CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 15.5 years ago

Interventions

Gabapentindrug

On Study day 1: 1200mg (single dose). Study day 2,3: 300mg TID, 900mg daily. Study day 4-7: 600mg TID 1800mg\* daily. Study day 8-11: 800mg TID 2400mg\* daily \[Optional increase to 2400 if pain scores are still 4 on NRS\] Study day 11: 1200mg TID 3600mg\* daily \[Optional increase to 3600 if pain scores are still \>4 on NRS\] \* May revert back to prior dose if adverse symptoms occur and are thought to be drug related. Up titration then will be preformed in 48 hours following deexcalation.

Placebodrug

Sugar Pill is administered similar to the protocol used for the investigational drug.